Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
J Intellect Disabil Res ; 68(5): 491-511, 2024 May.
Article in English | MEDLINE | ID: mdl-38303157

ABSTRACT

BACKGROUND: Individuals with Down syndrome (DS) have a heightened risk for various co-occurring health conditions, including congenital heart disease (CHD). In this two-part study, electronic medical records (EMRs) were leveraged to examine co-occurring health conditions among individuals with DS (Study 1) and to investigate health conditions linked to surgical intervention among DS cases with CHD (Study 2). METHODS: De-identified EMRs were acquired from Vanderbilt University Medical Center and facilitated creating a cohort of N = 2282 DS cases (55% females), along with comparison groups for each study. In Study 1, DS cases were one-by-two sex and age matched with samples of case-controls and of individuals with other intellectual and developmental difficulties (IDDs). The phenome-disease association study (PheDAS) strategy was employed to reveal co-occurring health conditions in DS versus comparison groups, which were then ranked for how often they are discussed in relation to DS using the PubMed database and Novelty Finding Index. In Study 2, a subset of DS individuals with CHD [N = 1098 (48%)] were identified to create longitudinal data for N = 204 cases with surgical intervention (19%) versus 204 case-controls. Data were included in predictive models and assessed which model-based health conditions, when more prevalent, would increase the likelihood of surgical intervention. RESULTS: In Study 1, relative to case-controls and those with other IDDs, co-occurring health conditions among individuals with DS were confirmed to include heart failure, pulmonary heart disease, atrioventricular block, heart transplant/surgery and primary pulmonary hypertension (circulatory); hypothyroidism (endocrine/metabolic); and speech and language disorder and Alzheimer's disease (neurological/mental). Findings also revealed more versus less prevalent co-occurring health conditions in individuals with DS when comparing with those with other IDDs. Findings with high Novelty Finding Index were abnormal electrocardiogram, non-rheumatic aortic valve disorders and heart failure (circulatory); acid-base balance disorder (endocrine/metabolism); and abnormal blood chemistry (symptoms). In Study 2, the predictive models revealed that among individuals with DS and CHD, presence of health conditions such as congestive heart failure (circulatory), valvular heart disease and cardiac shunt (congenital), and pleural effusion and pulmonary collapse (respiratory) were associated with increased likelihood of surgical intervention. CONCLUSIONS: Research efforts using EMRs and rigorous statistical methods could shed light on the complexity in health profile among individuals with DS and other IDDs and motivate precision-care development.


Subject(s)
Down Syndrome , Heart Defects, Congenital , Heart Failure , Female , Humans , Male , Electronic Health Records , Heart Defects, Congenital/complications , Cognition , Heart Failure/complications
2.
Neurology ; 77(20): 1812-8, 2011 Nov 15.
Article in English | MEDLINE | ID: mdl-22013176

ABSTRACT

OBJECTIVE: The clinical features and genetics of Rett syndrome (RTT) have been well studied, but examination of quality of life (QOL) is limited. This study describes the impact of clinical severity on QOL among female children and adolescents with classic RTT. METHODS: Cross-sectional and longitudinal analyses were conducted on data collected from an NIH-sponsored RTT natural history study. More than 200 participants from 5 to 18 years of age with classic RTT finished their 2-year follow-up at the time of analysis. Regression models after adjustment for their MECP2 mutation type and age at enrollment were used to examine the association between clinical status and QOL. RESULTS: Severe clinical impairment was highly associated with poor physical QOL, but worse motor function and earlier age at onset of RTT stereotypies were associated with better psychosocial QOL; conversely, better motor function was associated with poorer psychosocial QOL. CONCLUSIONS: Standard psychosocial QOL assessment for children and adolescents with RTT differs significantly with regard to their motor function severity. As clinical trials in RTT emerge, the Child Health Questionnaire 50 may represent one of the important outcome measures.


Subject(s)
Quality of Life/psychology , Rett Syndrome/physiopathology , Rett Syndrome/psychology , Adolescent , Child , Child, Preschool , Cross-Sectional Studies , Female , Follow-Up Studies , Humans , Methyl-CpG-Binding Protein 2/genetics , Mutation/genetics , Neuropsychological Tests , Severity of Illness Index
3.
Neurology ; 74(11): 909-12, 2010 Mar 16.
Article in English | MEDLINE | ID: mdl-20231667

ABSTRACT

BACKGROUND: Rett syndrome (RTT) is a neurodevelopmental disorder primarily seen in females, most with a mutation in MECP2. Epilepsy has been reported in 50%-80%. Previous reports were based on small sample sizes or parent-completed questionnaires, or failed to consider the impact of specific MECP2 mutations. METHODS: The Rare Disease Consortium Research Network for RTT is an NIH-funded project to characterize the clinical spectrum and natural history of RTT in advance of clinical trials. Evaluations include clinical status (classic vs atypical RTT), MECP2 mutations, clinical severity, and presence, frequency, and treatment of seizures. RESULTS: Enrollment as of June 2008 is 602; 528 (88%) meet clinical criteria for classic RTT. Of these, 493 (93%) have MECP2 mutations. Age range was 8 months to 64 years. A total of 360 (60%) were reported to have seizures, including 315 (60%) classic and 45 (61%) atypical RTT. Physician assessment of the 602 indicated that 48% had seizures. There was no significant difference in seizure occurrence by race/ethnicity. A significant age impact for seizures was seen and seizures were infrequent before age 2 years. MECP2 mutations most frequently associated with epilepsy were T158M (74%) and R106W (78%), and less frequently R255X and R306C (both 49%). Individuals with seizures had greater overall clinical severity, and greater impairment of ambulation, hand use, and communication. DISCUSSION: Seizures are common in Rett syndrome, have an age-related onset and occurrence, vary by mutation, and are associated with greater clinical severity. This information represents a key consideration for designing clinical trials.


Subject(s)
Epilepsy/genetics , Rett Syndrome/genetics , Adolescent , Adult , Age Factors , Age of Onset , Child , Child, Preschool , Epilepsy/complications , Female , Genetic Predisposition to Disease , Humans , Infant , Male , Methyl-CpG-Binding Protein 2/genetics , Middle Aged , Phenotype , Regression Analysis , Rett Syndrome/complications , Severity of Illness Index , Sex Factors , Young Adult
4.
Neurology ; 70(16): 1313-21, 2008 Apr 15.
Article in English | MEDLINE | ID: mdl-18337588

ABSTRACT

OBJECTIVE: To determine if a relationship exists between the clinical features of Rett syndrome, an X-linked dominant neurodevelopmental disorder, and specific mutations in MECP2. METHOD: Cross-sectional study of 245 girls and women with typical Rett syndrome seen between 1990 and 2004 in tertiary academic outpatient specialty clinics and who had complete MECP2 mutation analysis. A structured clinical evaluation was completed for each participant. The results were grouped by MECP2 mutation and compared. RESULTS: Participants with the R133C mutation are less severely affected than those with R168X or large DNA deletions (p < 0.05). Likewise, individuals with the R168X mutation are more severely affected than those with R294X and late carboxy-terminal truncating mutations (p < 0.05). Clinical differences are notable in ambulation, hand use, and language (p < 0.004), three cardinal features of Rett syndrome. Individuals with R168X are less likely to walk (p = 0.008), retain hand use (p = 0.002), or use words (p = 0.001). In contrast, those with carboxy-terminal truncations are more likely to walk (p = 0.007) and use words (p < 0.001). The R306C mutation, previously found to confer milder features, adversely affects only one clinical feature, language (p < 0.05). CONCLUSIONS: Specific mutations in MECP2 confer different severity. These results allow the design of therapies targeted toward the amelioration of expected problems. Furthermore, the distinct effects of MECP2 mutations on clinical severity must be considered in clinical intervention trials.


Subject(s)
Methyl-CpG-Binding Protein 2/genetics , Mutation/genetics , Rett Syndrome/genetics , Rett Syndrome/physiopathology , Severity of Illness Index , Cross-Sectional Studies , Female , Humans , Methyl-CpG-Binding Protein 2/physiology
6.
Neurology ; 64(6): 1088-90, 2005 Mar 22.
Article in English | MEDLINE | ID: mdl-15781839

ABSTRACT

The authors describe a 6-year-old girl with developmental delay, psychomotor regression, seizures, mental retardation, and autistic features associated with low CSF levels of 5-methyltetrahydrofolate, the biologically active form of folates in CSF and blood. Folate and B12 levels were normal in peripheral tissues, suggesting cerebral folate deficiency. Treatment with folinic acid corrected CSF abnormalities and improved motor skills.


Subject(s)
Autistic Disorder/drug therapy , Cerebral Cortex/drug effects , Cerebral Cortex/growth & development , Developmental Disabilities/drug therapy , Folic Acid Deficiency/drug therapy , Leucovorin/administration & dosage , Seizures/drug therapy , Adaptation, Physiological/drug effects , Adaptation, Physiological/physiology , Autistic Disorder/cerebrospinal fluid , Autistic Disorder/etiology , Cerebral Cortex/metabolism , Child , Developmental Disabilities/cerebrospinal fluid , Developmental Disabilities/etiology , Disease Progression , Female , Folic Acid/metabolism , Folic Acid Deficiency/cerebrospinal fluid , Folic Acid Deficiency/physiopathology , Genetic Predisposition to Disease , Humans , Intellectual Disability/drug therapy , Intellectual Disability/etiology , Intellectual Disability/metabolism , Mutation/genetics , Recovery of Function/drug effects , Recovery of Function/physiology , Reduced Folate Carrier Protein/genetics , Seizures/cerebrospinal fluid , Seizures/etiology , Tetrahydrofolates/cerebrospinal fluid , Transcription Factors/genetics , Treatment Outcome
7.
Cell ; 95(4): 483-94, 1998 Nov 13.
Article in English | MEDLINE | ID: mdl-9827801

ABSTRACT

Dorsal-ventral patterning within the embryonic ectoderm of Drosophila requires two TGFbeta ligands, DPP and SCW, and two type I TGFbeta receptors, TKV and SAX. In embryos lacking dpp signaling, increasing the level of TKV activity promotes progressively more dorsal cell types, while activation of SAX alone has no phenotypic consequences. However, SAX activity synergizes with TKV activity to promote dorsal development. Functional experiments suggest the two receptors have different ligands: DPP acts through TKV, and SCW acts through SAX. Furthermore, SOG, a negative regulator of this patterning process, preferentially blocks SCW activity. We propose that spatial regulation of the SAX pathway modulates TKV signaling to create positional information over the embryonic ectoderm.


Subject(s)
Body Patterning/physiology , Drosophila Proteins , Insect Proteins/physiology , Protein Serine-Threonine Kinases/physiology , Receptors, Cell Surface/physiology , Receptors, Transforming Growth Factor beta/physiology , Signal Transduction/physiology , Transforming Growth Factor beta/physiology , Animals , Drosophila , Gene Expression Regulation, Developmental/physiology , Genes, Insect/physiology
8.
Cell ; 86(4): 607-17, 1996 Aug 23.
Article in English | MEDLINE | ID: mdl-8752215

ABSTRACT

noggin is expressed in the Spemann organizer region of the Xenopus embryo and can promote dorsal cell fates within the mesoderm and neural development within the overlying ectoderm. Here, we show that noggin promotes ventral development in Drosophila, specifying ventral ectoderm and CNS in the absence of all endogenous ventral-specific zygotic gene expression. We utilize constitutively active forms of the dpp receptors to demonstrate that noggin blocks dpp signaling upstream of dpp receptor activation. These results suggest a mechanistic basis for the action of Spemann's organizer during Xenopus development and provide further support for the conservation of dorsal-ventral patterning mechanisms between arthropods and chordates.


Subject(s)
Drosophila Proteins , Drosophila melanogaster/embryology , Insect Hormones/physiology , Protein Serine-Threonine Kinases/physiology , Proteins/physiology , Receptors, Cell Surface/physiology , Xenopus laevis/embryology , Activin Receptors , Animals , Base Sequence , Bone Morphogenetic Proteins , Carrier Proteins , DNA Primers/chemistry , Ectoderm/cytology , Embryonic Induction , Epistasis, Genetic , Female , Humans , Male , Microinjections , Molecular Sequence Data , Morphogenesis , Proteins/pharmacology , RNA, Messenger/administration & dosage , Receptors, Growth Factor/physiology , Recombinant Proteins , Signal Transduction , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...